Variant report
Variant | nsv594938 |
---|---|
Chromosome Location | chr4:98976003-99027184 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:99001766..99003673-chr4:99063340..99066059,2 | MCF-7 | breast: | |
2 | chr4:98995356..98997429-chr4:98998775..99000432,2 | MCF-7 | breast: | |
3 | chr4:98967509..98968412-chr4:99013843..99014513,4 | MCF-7 | breast: | |
4 | chr4:98995356..98997429-chr4:98998775..99000432,2 | MCF-7 | breast: | |
5 | chr4:99002780..99005606-chr4:99010089..99012416,2 | MCF-7 | breast: | |
6 | chr4:99002780..99005606-chr4:99010089..99012416,2 | MCF-7 | breast: | |
7 | chr4:98765331..98767165-chr4:99012892..99015543,2 | K562 | blood: | |
8 | chr4:99012356..99014792-chr4:99062792..99064417,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000163116 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188725328 | chr4:98982416-98982417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs34509663 | chr4:98982531-98982532 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs551285497 | chr4:98982539-98982540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs569530604 | chr4:98982557-98982558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536840379 | chr4:98982589-98982590 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs7682991 | chr4:98982595-98982596 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs377255674 | chr4:98982696-98982697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs201764593 | chr4:98982758-98982759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs140688920 | chr4:98982766-98982767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs386677630 | chr4:98982767-98982768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs373422429 | chr4:98982768-98982769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs1727269 | chr4:98982769-98982770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs398063845 | chr4:98982771-98982772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs540794786 | chr4:98982787-98982788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs28415600 | chr4:98998667-98998668 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs574937205 | chr4:98998705-98998706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs541990288 | chr4:98998711-98998712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs560711750 | chr4:98998827-98998828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs560665164 | chr4:98998848-98998849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs116470471 | chr4:98998868-98998869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs546218611 | chr4:98998882-98998883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs11932942 | chr4:98998939-98998940 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs560150087 | chr4:98998955-98998956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs116474705 | chr4:98998961-98998962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs567249868 | chr4:98998988-98998989 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs550612652 | chr4:98999038-98999039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs569089024 | chr4:98999041-98999042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs147781873 | chr4:98999102-98999103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs2555390 | chr4:98999112-98999113 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs199900583 | chr4:98999191-98999192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs397994652 | chr4:98999197-98999198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs552326911 | chr4:98999329-98999330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs569138871 | chr4:98999367-98999368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs566997258 | chr4:98999379-98999380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs531870754 | chr4:98999389-98999390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs534283468 | chr4:98999403-98999404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs139465213 | chr4:98999426-98999427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs577176079 | chr4:98999451-98999452 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs35951881 | chr4:98999474-98999475 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs556600488 | chr4:98999545-98999546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs575043393 | chr4:98999630-98999631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs186273172 | chr4:98999663-98999664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs189380622 | chr4:98999670-98999671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs572650416 | chr4:98999694-98999695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs17550217 | chr4:98999699-98999700 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
46 | rs564954871 | chr4:98999722-98999723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs182020262 | chr4:98999730-98999731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572555237 | chr4:98999740-98999741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs187455164 | chr4:98999755-98999756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs190662071 | chr4:98999765-98999766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Cancer | 19907438 | CNVD |
Prostate cancer | 16573809 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 19197363 | CNVD |
Melanoma | 20688739 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Breast cancer | 22522925 | CNVD |
Gastric cancer | 16891809 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:98982400-98982800 | Enhancers | Dnd41 | blood |
2 | chr4:98998600-99000000 | Enhancers | Dnd41 | blood |
3 | chr4:99014600-99015800 | Enhancers | HMEC | breast |
4 | chr4:99014600-99016000 | Enhancers | Fetal Intestine Large | intestine |
5 | chr4:99014600-99016000 | Enhancers | Fetal Intestine Small | intestine |
6 | chr4:99014800-99015800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr4:99014800-99015800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
8 | chr4:99014800-99016000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
9 | chr4:99014800-99016000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
10 | chr4:99014800-99016000 | Enhancers | NHEK | skin |
11 | chr4:99015000-99016000 | Enhancers | Stomach Mucosa | stomach |
12 | chr4:99015000-99016200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
13 | chr4:99015600-99016000 | Enhancers | Placenta Amnion | Placenta Amnion |
14 | chr4:99025200-99026200 | Weak transcription | Brain Substantia Nigra | brain |